| 2024-04-05 18:53 | CC:NXG | NexgenRx Inc | 0.22 | News Release200 | NexgenRx omits 2023 net P&L in NR, talks revenue |
| 2024-04-05 18:04 | CC:NXG | NexgenRx Inc | 0.22 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-04-05 18:04 | CC:NXG | NexgenRx Inc | 0.22 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-12-20 17:47 | CC:NXG | NexgenRx Inc | 0.22 | News Release200 | NexgenRx to pay dividend to common, preferred holders |
| 2023-11-23 17:38 | CC:NXG | NexgenRx Inc | 0.25 | News Release200 | NexgenRx talks EBITDA, omits Q3 P&L from NR |
| 2023-11-23 16:25 | CC:NXG | NexgenRx Inc | 0.25 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-23 16:23 | CC:NXG | NexgenRx Inc | 0.25 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-21 17:17 | CC:NXG | NexgenRx Inc | 0.315 | News Release200 | NexgenRx talks revenue, omits P&L from Q2 NR |
| 2023-08-21 15:47 | CC:NXG | NexgenRx Inc | 0.315 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-08-21 15:44 | CC:NXG | NexgenRx Inc | 0.315 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-06-15 18:02 | CC:NXG | NexgenRx Inc | 0.32 | News Release200 | NexgenRx to pay 0.5-cent dividend June 30 |
| 2023-05-18 20:16 | CC:NXG | NexgenRx Inc | 0.32 | News Release200 | NexgenRx talks revenue, omits Q1 P&L from NR |
| 2023-05-18 17:57 | CC:NXG | NexgenRx Inc | 0.32 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-18 17:57 | CC:NXG | NexgenRx Inc | 0.32 | SEDAR MD & A815 | SEDAR MD & A |